Cargando…
Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
Activating mutations in EGFR predict benefit from tyrosine kinase inhibitor therapy for patients with advanced non-small cell lung cancer. Directing patients to appropriate therapy depends on accurate and timely EGFR assessment in the molecular pathology laboratory. This article describes the analyt...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870499/ https://www.ncbi.nlm.nih.gov/pubmed/35202431 http://dx.doi.org/10.1371/journal.pone.0264201 |